KPRX
NASDAQ
US
Kiora Pharmaceuticals, Inc. - Common Stock
$1.94
▼ $-0.01
(-0.51%)
Vol 39K
5
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$7.2M
ROE
-36.4%
Margin
70.1%
D/E
0.00
Beta
-0.83
52W
$2–$4
Wall Street Consensus
7 analysts · Apr 20262
Strong Buy
4
Buy
1
Hold
0
Sell
0
Strong Sell
85.7%
Buy Rating
Price Chart
Similar Stocks
Earnings
Beat rate: 60.0%
Next Report
May 07, 2026
EPS Estimate: $-0.72
| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Mar 2026 | $-0.72 | — | — |
| Dec 2025 | $-0.68 | $-1.59 | $-0.91 |
| Sep 2025 | $-0.75 | $0.01 | +$0.76 |
| Jun 2025 | $-0.62 | $-0.54 | +$0.08 |
Quarterly Revenue & Earnings
| Quarter | 2024-0… | 2024-1… | 2025-0… | 2025-0… | 2025-0… |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Net Income | -$3.4M | -$4.2M | -$2.2M | -$2.2M | $27K |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -47.2% | -47.2% | -47.2% | -47.2% | -47.2% | -36.4% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | — | 70.1% | 70.1% | 70.1% | 70.1% | 70.1% |
| Gross Margin | — | — | — | — | — | — |
| D/E Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Current Ratio | 7.76 | 7.76 | 7.76 | 7.76 | 7.76 | 8.79 |
Key Ratios
ROA (TTM)
-25.8%
P/S (TTM)
0.45
P/B
0.4
EPS (TTM)
$-2.05
CF/Share
$-6.49
Rev Growth 3Y
+81.3%
52W High
$4.18
52W Low
$1.76
$1.76
52-Week Range
$4.18
Financial Health
Free Cash Flow
-$1.3M
Net Debt
-$5.1M
Cash
$5.5M
Total Debt
$404K
As of Sep 30, 2025
How does KPRX compare to Pharmaceuticals peers?
Peer group: Micro-cap Pharmaceuticals (All) · 171 companies
KPRX valuation vs Pharmaceuticals peers
P/E ratio
—
▼
0%
below
peers
(22.4)
vs Peers
vs Industry
Undervalued
P/S ratio
0.5
▼
91%
below
peers
(5.0)
vs Peers
vs Industry
Undervalued
P/B ratio
0.4
▼
82%
below
peers
(2.1)
vs Peers
vs Industry
Undervalued
Div yield
—
▼
0%
below
peers
(2.0%)
vs Peers
vs Industry
Low yield
KPRX profitability vs Pharmaceuticals peers
ROE
-36.4%
▲
33%
above
peers
(-54.3%)
vs Peers
vs Industry
Below avg
Net margin
70.1%
▲
248%
above
peers
(-47.4%)
vs Peers
vs Industry
Below avg
Gross margin
—
▼
0%
below
peers
(68.3%)
vs Peers
vs Industry
In line
ROA
-25.8%
▲
31%
above
peers
(-37.4%)
vs Peers
vs Industry
Below avg
KPRX financial health vs Pharmaceuticals peers
D/E ratio
0.0
▼
100%
below
peers
(1.5)
vs Peers
vs Industry
Low debt
Current ratio
8.8
▲
162%
above
peers
(3.4)
vs Peers
vs Industry
Strong liquidity
Beta
-0.8
▼
188%
below
peers
(0.9)
vs Peers
vs Industry
More volatile
KPRX fundamentals radar
KPRX
Peer median
Industry
KPRX profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
KPRX vs peers: key metrics
Latest News
No related news yet